StockData
Connect Biopharma Holdings Ltd logo

Connect Biopharma Holdings Ltd (CNTB) stock

CNTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.58−0.06 (-9.98%)

Close on Nov 17, 2026Market cap $36.45MP/E –Yield –

Connect Biopharma total assets

Total assets on the balance sheet at the end of each period.

Connect Biopharma's total assets was $43.47M at Jun 30, 2026. For fiscal 2025 it was $56.08M, down 44.6% from the year before. The highest annual figure on record is $291.05M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$56.08M-44.6%
FY2024Dec 31, 2024$101.28M-20.5%
FY2023Dec 31, 2023$127.38M-26.8%
FY2022Dec 31, 2022$174.01M-40.2%
FY2021Dec 31, 2021$291.05M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$43.47M-47.4%
Q1 FY2026Mar 31, 2026$60.07M-35.2%
Q4 FY2025Dec 31, 2025$56.08M-44.6%
Q3 FY2025Sep 30, 2025$67.36M-44.1%
Q2 FY2025Jun 30, 2025$82.73M-35.1%
Q1 FY2025Mar 31, 2025$92.69M-35.7%
Q4 FY2024Dec 31, 2024$101.28M-41.8%
Q2 FY2024Jun 30, 2024$120.57M-48.6%
Q4 FY2023Dec 31, 2023$127.38M-56.2%
Q2 FY2023Jun 30, 2023$144.08M–
Q4 FY2022Dec 31, 2022$174.01M–
Q2 FY2022Jun 30, 2022$234.70M–
Q4 FY2021Dec 31, 2021$291.05M–

More Connect Biopharma figures

See a number that looks wrong?